All In Biotech

Free tool

FAERS Monitor: Kisqali

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209092 or its brand name (Kisqali, Ribociclib Succinate). Reports on generic versions are filed under their own applications.

Reports

32,716

Serious

27,086

83% of reports

Hospitalization

7,508

Death reported

4,684

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • neutropenia4,342
  • fatigue3,986
  • nausea3,932
  • malignant neoplasm progression2,842
  • death2,554
  • vomiting2,210
  • diarrhoea2,125
  • white blood cell count decreased2,076
  • pain1,940
  • metastases to bone1,825
  • asthenia1,680
  • breast cancer metastatic1,678
  • malaise1,670
  • dyspnoea1,652
  • anaemia1,557

Reports by year received

View as table
YearReports
20143
20163
2017507
20181,211
20192,156
20203,064
20213,676
20224,013
20235,960
20243,887
20254,574
20263,662

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,443 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer metastaticSignal1,678118.9113.0165,556
metastases to boneSignal1,82580.376.6127,058
neutropeniaSignal4,34221.220.681,301
malignant neoplasm progressionSignal2,84218.317.745,455
white blood cell count decreasedSignal2,07612.512.021,712
anaemiaSignal1,5575.35.05,407
fatigueSignal3,9863.33.26,611
nauseaSignal3,9323.23.16,165
vomitingSignal2,2103.02.93,061
astheniaSignal1,6802.92.72,089
malaiseSignal1,6702.52.31,462
diarrhoeaSignal2,1252.12.01,292
painSignal1,9402.01.91,046
death2,5541.91.81,147
dyspnoea1,6521.91.8695

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.